Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SurgLine International, Inc. (SGLN)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00000.0000 (0.00%)
At close: 03:50PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0000
Open0.0000
BidN/A x N/A
AskN/A x N/A
Day's Range0.0000 - 0.0000
52 Week Range0.0000 - 0.0013
Volume200,000
Avg. Volume23,713,860
Market Cap5,690
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SGLN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SURGLINE INTL INC
    Analyst Report: Stryker Corp.Based in Kalamazoo, Michigan, Stryker manufactures and markets medical devices, primarily in the orthopedic market. The Orthopedics segment sells joint reconstructive products (hips, knees and shoulders) and trauma implants. The MedSurg Equipment segment sells powered surgical instruments, surgical navigation systems, endoscopic products, medical video imaging equipment, and hospital beds and patient-handling systems. The Neurotechnology unit includes the neurovascular business as well as the interventional spine and spinal implants business.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement